• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素性排卵功能障碍或功能性女性雄激素过多症:摒弃多囊卵巢综合征这一术语的理由。

Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.

作者信息

Behera Millie, Price Thomas, Walmer David

机构信息

Reproductive Endocrinology and Fertility Division, Department Of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.

出版信息

Fertil Steril. 2006 Nov;86(5):1292-5. doi: 10.1016/j.fertnstert.2006.06.048.

DOI:10.1016/j.fertnstert.2006.06.048
PMID:17070182
Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders seen among reproductive-age women, with a prevalence of 4%-9% depending on the criteria used to define the syndrome. The diagnostic criteria for PCOS have been surprisingly controversial and confusing for patients, clinicians, and researchers. We believe that the confusion surrounding PCOS arises almost entirely because its name refers to a trait that is inconsistently present and irrelevant to both the etiology and the treatment of the disorder. We suggest that merely abandoning the term PCOS will cure much of what has ailed us for decades and allow us to focus on the etiology and treatment of the causes of what the experts in this field have come to recognize as functional female hyperandrogenism.

摘要

多囊卵巢综合征(PCOS)是育龄女性中最常见的内分泌疾病之一,根据用于定义该综合征的标准,其患病率为4% - 9%。PCOS的诊断标准对患者、临床医生和研究人员来说一直存在惊人的争议且令人困惑。我们认为,围绕PCOS的困惑几乎完全源于其名称所指的特征并不一致存在,且与该疾病的病因和治疗均无关。我们建议,仅仅摒弃“PCOS”这个术语就能解决困扰我们数十年的诸多问题,并使我们能够专注于该领域专家已认识到的功能性女性雄激素过多症病因的研究及其治疗。

相似文献

1
Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.雌激素性排卵功能障碍或功能性女性雄激素过多症:摒弃多囊卵巢综合征这一术语的理由。
Fertil Steril. 2006 Nov;86(5):1292-5. doi: 10.1016/j.fertnstert.2006.06.048.
2
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.多囊卵巢综合征的诊断、表型及患病率
Fertil Steril. 2006 Jul;86 Suppl 1:S7-8. doi: 10.1016/j.fertnstert.2006.03.012.
3
The spectrum of androgen excess disorders.雄激素过多症的谱系
Fertil Steril. 2006 Jun;85(6):1582-5. doi: 10.1016/j.fertnstert.2006.02.069.
4
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.多囊卵巢综合征的诊断、流行病学及遗传学
Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):193-205. doi: 10.1016/j.beem.2006.02.005.
5
Secondary forms of polycystic ovary syndrome.多囊卵巢综合征的继发性形式。
Trends Endocrinol Metab. 2004 Jul;15(5):204-10. doi: 10.1016/j.tem.2004.05.009.
6
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.在对比不同诊断标准的情况下,对社区样本中多囊卵巢综合征的流行情况进行评估。
Hum Reprod. 2010 Feb;25(2):544-51. doi: 10.1093/humrep/dep399. Epub 2009 Nov 12.
7
Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.根据2003年修订的诊断标准,用于评估被归类为患有多囊卵巢综合征(PCOS)的女性高雄激素血症的内分泌学标志物。
Eur J Med Res. 2006 Dec 14;11(12):540-4.
8
The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research.多囊卵巢综合征的诊断:这些标准对于临床研究来说不够稳健。
Clin Endocrinol (Oxf). 2007 Dec;67(6):811-5. doi: 10.1111/j.1365-2265.2007.02932.x. Epub 2007 Aug 29.
9
Diagnosis of polycystic ovary syndrome.多囊卵巢综合征的诊断
Clin Obstet Gynecol. 2007 Mar;50(1):168-77. doi: 10.1097/GRF.0b013e31802f351b.
10
[Polycystic ovary syndrome].[多囊卵巢综合征]
J Gynecol Obstet Biol Reprod (Paris). 2000 May;29(3):298-301.

引用本文的文献

1
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey.多囊卵巢综合征:患者和健康专业人员对临床特征、现有名称及重新命名的观点:一项纵向国际在线调查
EClinicalMedicine. 2025 May 28;84:103287. doi: 10.1016/j.eclinm.2025.103287. eCollection 2025 Jun.
2
Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding.重新思考术语:关于重新命名多囊卵巢综合征以增强对病理生理学理解的观点
Clin Med Insights Endocrinol Diabetes. 2024 Oct 28;17:11795514241296777. doi: 10.1177/11795514241296777. eCollection 2024.
3
The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment.
多囊卵巢综合征(PCOS)女性的心脏代谢风险:从病理生理学到诊断和治疗。
Medicina (Kaunas). 2024 Oct 10;60(10):1656. doi: 10.3390/medicina60101656.
4
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.多囊卵巢综合征:定义、病因、诊断与治疗。
Nat Rev Endocrinol. 2018 May;14(5):270-284. doi: 10.1038/nrendo.2018.24. Epub 2018 Mar 23.
5
Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?多囊卵巢综合征:是时候将PCOS重新命名为HA-PODS了吗?
J Obstet Gynaecol India. 2016 Apr;66(2):81-7. doi: 10.1007/s13224-016-0851-9. Epub 2016 Mar 11.
6
Polycystic ovary syndrome: what's in a name?多囊卵巢综合征:名称背后有何含义?
J Clin Endocrinol Metab. 2014 Apr;99(4):1142-5. doi: 10.1210/jc.2013-3996. Epub 2014 Feb 3.